Switzerland-based Lonza Group AG (LZAGF.PK) said its first-quarter business performance was solid and in line with expectations. Looking ahead, the firm expects its second half of 2013 to be stronger than the first half of the year.
The chemical and pharmaceutical ingredients maker noted that in the first quarter, Specialty Ingredients market segment showed a good performance, while, Pharma&Biotech market segment had a slow start as anticipated.
Lonza added that strong cost controls and process improvements continue across the organization and head count reduction is in implementation phase.
Lonza also reiterated its 2013 EBIT guidance growth of about 10%.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.